Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Altimmune Inc shares valued at $5,784 were purchased by Sohn Catherine A. on Mar 17 ’25. At $5.78 per share, Sohn Catherine A. acquired 1,000 shares. The insider’s holdings grew to 1,000 shares worth approximately $3650.0 following the completion of this transaction.
Also, WEAVER GREGORY L purchased 10,000 shares, netting a total of over 51,996 in proceeds. Following the buying of shares at $5.20 each, the insider now holds 10,000 shares.
Before that, Drutz David had sold 16,011 shares from its account. In a trade valued at $110,547, the Director traded Altimmune Inc shares for $6.90 each. Upon closing the transaction, the insider’s holdings decreased to 16,011 shares, worth approximately $0.15 million.
Analysts at William Blair started covering the stock with ‘”a Mkt perform”‘ outlook in a report released in late February. As of January 08, 2025, Stifel has initiated its “Buy” rating for ALT. Earlier on November 12, 2024, UBS initiated its rating. Their recommendation was “a Buy” for ALT stock.
Analyzing ALT Stock Performance
On last trading session,, Altimmune Inc [NASDAQ: ALT] plunged -4.70% to $3.65. The stock’s lowest price that day was $3.58, but it reached a high of $3.9 in the same session. During the last five days, there has been a drop of approximately -14.92%. Over the course of the year, Altimmune Inc shares have dropped approximately -45.93%.
Support And Resistance Levels for Altimmune Inc (ALT)
RSI (Relative Strength Index) is 34.68 on the 14-day chart, showing neutral technical sentiment.
Is Altimmune Inc subject to short interest?
Stocks of Altimmune Inc saw a sharp rise in short interest on 2025-07-15 jumping by 3.7 million shares to 28.1 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 24.4 million shares. A jump of 13.16% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.47 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.47.
Which companies own the most shares of Altimmune Inc (ALT)?
In terms of Altimmune Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 552.74% from the previous closing price of $3.83. Analysts anticipate Altimmune Inc stock to reach 35 by 2025, with the lowest price target being 12. In spite of this, 6 analysts ranked Altimmune Inc stock as Buy at the end of 2025.
